MAIA · MAIA Biotechnology, Inc.

NYSE MKT LLC - BOATS Real Time Price • USD

Maia Biotechnology Inc (MAIA)

NYSE MKT LLC Biotechnology
Move probability → Options chain →
$1.13 +0.02 (+1.80%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE $1.13
$1.13 $1.15
52-WEEK RANGE $1.13
$0.87 $3.19

What's happening

Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.

Key Statistics

Market Cap$70.4M
P/E (TTM1)—
EPS2 (TTM)$-0.64
Div Yield—
Beta30.28
Volume9,336
Open1.15
Prev Close1.11
Bid / Ask0.98 / 0.00
Next Earnings 2026-11-05

Analyst Recommendations

Strong buy 2 Buy 4 Hold 1 Sell 0 Strong sell 0

Aggregate ratings for 2026-10-01 (7 analysts polled by Finnhub) — consensus count.

Performance Overview (Trailing returns vs S&P 500 benchmark)

YTD RETURN
MAIA -26.80%
vs S&P 500 -39.57%
1-YEAR RETURN
MAIA -15.15%
vs S&P 500 -29.71%
6-MONTH RETURN
MAIA -15.79%
3-MONTH RETURN
MAIA -15.79%

Valuation Measures & Ratios

Enterprise Value4$41.6M
Forward P/E5—
PEG Ratio6-0.24
Price / Sales (TTM1)—
Price / Book74.23
EV4 / Revenue—
EV4 / EBITDA—
Profit Margin—
Operating Margin—
Return on Equity (ROE8)-211.15%
Return on Assets (ROA9)-126.26%
Avg Volume (3M)532,350
Quarterly history (5 periods)
Measure Jun '26Mar '26Sep '25Jun '25Mar '25
Market cap $88.0M $63.2M $51.1M $52.0M $43.2M
P/E -3.08 -2.52 -2.38 -2.42 -1.78
Price/Book 4.26 2.28 1226.56 13.41 8.74
ROE -138.15% -90.54% -51604.03% -554.07% -489.63%
ROA -101.14% -71.16% -182.51% -194.46% -203.97%

Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).

Glossary — what these abbreviations mean
1. TTM
Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
2. EPS
Earnings per share — net income divided by diluted shares outstanding.
3. Beta
A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
4. EV (Enterprise Value)
Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
5. Forward P/E
Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
6. PEG Ratio
P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
7. Price / Book
Share price divided by book value (assets minus liabilities) per share.
8. ROE
Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
9. ROA
Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
10. MRQ
Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
11. YoY
Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.

Short Interest

Shares Short2,690,687
Change from Prior Settlement+28.20%
% of Float—
Days to Cover (Short Ratio)3.43

Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.

Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.

Price history

Events

Drag horizontally to zoom into a section; use Reset view to restore all observations.

Technical signal summary

Calculating from the latest year of daily price history…

Calculating…
Show Technical Analysis Breakdown ▾ 10 Indicators

Not investment advice — read several signals together.

Indicators None active

Add lines over the price chart or a panel below it. Your choices are saved on this device.

Starter sets
Trend
Oscillators
Volume/volatility
Loading chart…

History limited by data provider; markers are heuristics, not signals.

Peer and sector context

No reviewed peer group is available for this symbol.

Balanced evidence

A deterministic summary of sourced facts—not an AI verdict.

Potential strengths

  • Latest SEC filing is Form 8-K, filed 2026-10-06; review it for current changes and risks. SEC EDGAR ↗

Potential concerns

Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.

Financials

Income statement

Line item Jun '26Mar '26Sep '25Jun '25Mar '25Sep '24Jun '24Mar '24
Operating income -$8.3M -$6.9M -$9.4M -$5.2M -$5.4M -$4.2M -$3.8M -$3.9M
Net income -$7.9M -$6.4M -$8.9M -$5.3M -$4.5M -$2.7M -$8.9M -$8.1M
EPS (diluted) $-0.13 $-0.14 $-0.27 $-0.18 $-0.16 $-0.11 $-0.40 $-0.46
EPS (basic) $-0.13 $-0.14 $-0.27 $-0.18 $-0.16 $-0.11 $-0.40 $-0.46

Balance sheet

Line item Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24
Total assets $28.2M $35.3M $9.7M $11.8M $11.0M $11.9M $10.2M $9.2M
Total liabilities $7.6M $7.6M $7.3M $11.7M $7.2M $6.9M $6.5M $7.6M
Stockholders' equity $20.7M $27.8M $2.4M $41.7K $3.9M $4.9M $3.6M $1.6M
Total current assets $28.2M $35.3M $9.7M $11.8M $11.0M $11.9M $10.2M $9.2M
Total current liabilities $6.3M $6.3M $5.8M $10.0M $5.0M $5.1M $3.8M $3.6M
Cash & equivalents $0 $0 $0 $0 $0 $0 $0 $0

Cash flow

Line item Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24
Operating cash flow -$6.8M -$5.3M -$7.0M -$3.5M -$4.1M -$4.2M -$3.9M -$3.5M
Financing cash flow -$65.0K $31.1M $4.8M $4.2M $3.4M $5.5M $4.8M $626.8K
Share-based compensation $723.9K $650.0K $810.8K $646.9K $802.5K $371.5K $693.4K $455.4K
Change in accounts payable -$144.8K $940.9K -$1.1M $1.5M -$153.0K $359.1K $369.3K -$115.3K

Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.

Institutional holders

SEC Form 13F filers holding MAIA as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.

Institutional ownership is not available for this symbol right now.

Insider activity

Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.

Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-06-01 to 2026-09-14

Recent transactions

  • Insiders have net bought 407,778 shares over the last 182 days, across 10 purchases and 0 sales.
  • Most recent: Vitoc Vlad (Chief Executive Officer) — Open market purchase of 73,000 shares on 2026-09-14.

Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.

Insider purchases & sales, last 6 months

Purchases (open market)407,778 sh(10 txns)
Sales (open market)0 sh(0 txns)
Net Shares+407,778

Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.

Insider roster

NameTitleMost Recent TransactionDateShares
Vitoc VladChief Executive OfficerOpen market purchase2026-09-1473,000
Guerrero RamiroDirectorOpen market purchase2026-09-1037,595
Smith StanDirectorOpen market purchase2026-06-0175,000
Gryaznov SergeiChief Scientific OfficerOpen market purchase2026-06-012,000

Recent transactions

DateInsiderTitleTransactionSharesPrice
2026-09-14Vitoc VladChief Executive OfficerOpen market purchase 73,000$1.37
2026-09-10Guerrero RamiroDirectorOpen market purchase 37,595$1.32
2026-08-28Guerrero RamiroDirectorOpen market purchase 46,620$1.35
2026-08-27Guerrero RamiroDirectorOpen market purchase 78,239$1.39
2026-08-26Guerrero RamiroDirectorOpen market purchase 8,931$1.39
2026-08-24Guerrero RamiroDirectorOpen market purchase 1,794$1.33
2026-08-20Guerrero RamiroDirectorOpen market purchase 11,899$1.37
2026-06-01Vitoc VladChief Executive OfficerOpen market purchase 72,700$1.39
2026-06-01Smith StanDirectorOpen market purchase 75,000$1.34
2026-06-01Gryaznov SergeiChief Scientific OfficerOpen market purchase 2,000$1.34

Recent SEC filings

Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.

Source: SEC EDGAR submissions · updated 2026-10-22 03:32 UTC

FiledFormReport periodOfficial filing
2026-10-068-K2026-10-06 View on SEC.gov →
2026-10-0242026-09-30 View on SEC.gov →
2026-10-0242026-09-30 View on SEC.gov →
2026-10-0242026-09-30 View on SEC.gov →
2026-10-0242026-09-30 View on SEC.gov →
2026-10-0242026-09-30 View on SEC.gov →
2026-10-0242026-09-30 View on SEC.gov →
2026-09-1542026-09-14 View on SEC.gov →
2026-09-1442026-09-10 View on SEC.gov →
2026-09-0142026-08-26 View on SEC.gov →
2026-08-2642026-08-24 View on SEC.gov →
2026-08-2442026-08-20 View on SEC.gov →

Headlines about MAIA (MAIA Biotechnology, Inc.). Links open the publisher — we don’t host full articles.

SEC filings ↓

← Back to the full dashboard · My watchlist